Pro Share Advisors LLC Immunity Bio, Inc. Transaction History

Pro Share Advisors LLC

$48.7 Billion
Q2 2025

A detailed history of Pro Share Advisors LLC transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 80,128 shares of IBRX stock, worth $201,121. This represents 0.0% of its overall portfolio holdings.

Number of Shares

80,128

Previous 66,023 21.36%

Holding current value

$201,121

Previous $198,000 6.57%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 07, 2025	BUY	$1.89 - $3.44 $26,658 - $48,521	14,105 Added 21.36%	80,128 $211,000
Q1 2025 May 08, 2025	SELL	$2.32 - $3.9 $17,980 - $30,225	-7,750 Reduced 10.51%	66,023 $198,000
Q4 2024 Feb 13, 2025	BUY	$2.56 - $6.17 $13,468 - $32,460	5,261 Added 7.68%	73,773 $188,000
Q3 2024 Nov 13, 2024	BUY	$3.32 - $6.7 $26,755 - $53,995	8,059 Added 13.33%	68,512 $254,000
Q2 2024 Aug 13, 2024	SELL	$4.82 - $9.15 $48,971 - $92,964	-10,160 Reduced 14.39%	60,453 $382,000
Q1 2024 May 08, 2024	BUY	$3.23 - $6.17 $19,392 - $37,044	6,004 Added 9.29%	70,613 $379,000
Q4 2023 Feb 14, 2024	BUY	$1.25 - $5.21 $24,976 - $104,101	19,981 Added 44.77%	64,609 $324,000
Q3 2023 Nov 13, 2023	BUY	$1.29 - $3.1 $2,683 - $6,448	2,080 Added 4.89%	44,628 $75,000
Q2 2023 Aug 10, 2023	BUY	$1.53 - $6.41 $6,403 - $26,825	4,185 Added 10.91%	42,548 $118,000
Q1 2023 May 11, 2023	SELL	$1.35 - $4.78 $7,125 - $25,228	-5,278 Reduced 12.09%	38,363 $69,000
Q4 2022 Feb 02, 2023	BUY	$4.35 - $6.77 $4,106 - $6,390	944 Added 2.21%	43,641 $221,000
Q3 2022 Nov 04, 2022	BUY	$3.65 - $6.43 $9,161 - $16,139	2,510 Added 6.25%	42,697 $212,000
Q2 2022 Aug 01, 2022	SELL	$2.68 - $6.14 $37,530 - $85,984	-14,004 Reduced 25.84%	40,187 $150,000
Q1 2022 May 10, 2022	SELL	$5.05 - $7.53 $84,430 - $125,894	-16,719 Reduced 23.58%	54,191 $304,000
Q4 2021 Feb 08, 2022	SELL	$5.67 - $10.18 $121,360 - $217,892	-21,404 Reduced 23.19%	70,910 $431,000
Q3 2021 Nov 12, 2021	BUY	$9.17 - $14.24 $54,864 - $85,197	5,983 Added 6.93%	92,314 $899,000
Q2 2021 Aug 13, 2021	BUY	$13.41 - $22.4 $842,241 - $1.41 Million	62,807 Added 266.99%	86,331 $1.23 Million
Q1 2021 May 14, 2021	BUY	$12.83 - $42.25 $301,812 - $993,889	23,524 New	23,524 $558,000

Others Institutions Holding IBRX

# of Institutions

272

Shares Held

120M

Call Options Held

2.49M

Put Options Held

3.14M

View Full List

About ImmunityBio, Inc.

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

More about IBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Immunity Bio, Inc. Transaction History